A Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular Carcinoma
- First Posted Date
- 2014-08-06
- Last Posted Date
- 2016-03-14
- Lead Sponsor
- Oncozyme Pharma Inc.
- Target Recruit Count
- 29
- Registration Number
- NCT02210182
- Locations
- 🇨🇦
Dr. Kelly Burak, Calgary, Alberta, Canada
🇨🇦Dr Morris Sherman, Toronto, Ontario, Canada
🇨🇦Dr Marc Bilodeau, Montreal, Quebec, Canada
An Exploratory Study of OCZ103-OS in Combination With Standard of Care in Stage IV Non-Small Cell Lung Cancer (NSCLC) Patients
Phase 2
Completed
- Conditions
- Non-small Cell Lung Cancer
- Interventions
- First Posted Date
- 2013-05-01
- Last Posted Date
- 2014-10-21
- Lead Sponsor
- Oncozyme Pharma Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT01844791
- Locations
- 🇵🇱
Ewa Kalinka-Warzocha, Lodz, Poland
Using OCZ103-OS in Patients With Unresectable and Locally Recurrent or Metastatic Colorectal Cancer Undergoing Standard Chemotherapy
Phase 2
Completed
- Conditions
- Colorectal Cancer
- Interventions
- Drug: OCZ103-OS [pentamidine bis(2-hydroxyethanesulfonate)], mFOLFOX6 or FOLFIRI
- First Posted Date
- 2011-06-22
- Last Posted Date
- 2014-10-21
- Lead Sponsor
- Oncozyme Pharma Inc.
- Target Recruit Count
- 53
- Registration Number
- NCT01378143
- Locations
- 🇨🇦
CHUM-St. Luc Hospital, Montreal, Quebec, Canada
🇨🇦Hotel-Dieu de Quebec, Quebec, Canada
🇨🇦CSSS Champlain - Charles-Lemoyne Hospital, Greenfield Park, Quebec, Canada
A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy
- First Posted Date
- 2008-12-18
- Last Posted Date
- 2011-06-28
- Lead Sponsor
- Oncozyme Pharma Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT00810953
- Locations
- 🇨🇦
McGill University, Montreal, Quebec, Canada
A Safety Study of Pentamidine in Patients With Metastatic Colon Cancer Undergoing Standard Chemotherapy as Second-line and/or Third-line Treatment
- First Posted Date
- 2008-12-17
- Last Posted Date
- 2011-06-28
- Lead Sponsor
- Oncozyme Pharma Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT00809796
- Locations
- 🇨🇦
Jewish General Hospital, Montreal, Quebec, Canada
© Copyright 2025. All Rights Reserved by MedPath